Peer-Reviewed Publications

      Real-time monitoring of suspended particulate matter in indoor air: Validation and application of a light-scattering sensor

      Susz, A.; Pratte, P.; Goujon-Ginglinger, C.
      Published
      Jul 27, 2020
      DOI
      10.4209/aaqr.2019.11.0604
      Link to publication
      Topic
      Summary

      Since the 1950s, awareness of the impact of air pollution on human health has been growing. Of the many recognized air pollutants, suspended particulate matter has received the most attention, as both PM2.5 and PM10 can affect humans upon inhalation. Consequently, PM monitoring is critical to linking indoor pollution and exposure, and a validated measuring instrument is essential. Portable monitors, which track temporal changes in the aerosol mass concentration in real time, are a faster alternative to offline gravimetric techniques, which provide only averaged values. Hence, this study evaluated the performance of the DustTrak DRX aerosol monitor in assessing indoor air quality and validated its ability to measure complex aerosols. Three DustTrak units were used to measure different aerosols, e.g., ambient air, polystyrene latex (PSL) spheres, and environmental tobacco smoke (ETS), and the results were compared to those obtained with the standard gravimetric method. Notably, the bias of the DustTrak relative to the gravimetric method for ETS measurements ranged from 2% to 15% when a photometric calibration factor (PCF) of 0.38 was applied. Additionally, the working range of the tested units was established, and the limits of detection and quantification were found to be 5 and 15 µg m–3, respectively. Finally, in order to serve as an alternative to the gravimetric method, these instruments must be accredited for PM measurement in accordance with standards such as ISO 17025.

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.